Jin Wang

Phase I Dose‐Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors

Ling Gao, D. Ji, Junning Cao, 2017, The oncologist.

Targeting KRAS in PDAC: A New Way to Cure It?

Zuojia Liu, Jin Wang, Q. He, 2022, Cancers.

Emerging Potential Mechanism and Therapeutic Target of Ferroptosis in PDAC: A Promising Future

Zuojia Liu, Jin Wang, Xunzhe Yin, 2022, International journal of molecular sciences.

Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment

Zuojia Liu, Xiangyu Guo, Jin Wang, 2022, International journal of molecular sciences.

Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy.

David S Mendelson, M. Morris, H. Scher, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease

Zuojia Liu, Xiangyu Guo, Jin Wang, 2023, International journal of molecular sciences.

Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.

Zuojia Liu, Jin Wang, Xunzhe Yin, 2023, Phytomedicine : international journal of phytotherapy and phytopharmacology.